Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>RUA Life Sciences operates in the medical device industry, specialising in implantable devices using patented biomaterials.</li>
<li>Progress was reported at the AGM Trading update given on 17 March 2026 for the 18 months to the new year-end September 2025).</li>
<li>Revenue for 18m Sept25 is £6.7m against £2.2m for 12m March 24. There are four divisions, with two being revenue-producing. </li>
</ul>


RUA Life Sciences operates in the medical device industry, specialising in implantable devices using patented biomaterials.
Progress was reported at the AGM Trading update given on 17 March 2026 for the 18 months to the new year-end September 2025).
Revenue for 18m Sept25 is £6.7m against £2.2m for 12m March 24. There are four divisions, with two being revenue-producing. 


RUA Life Sciences

Hybridan Research: RUA Life Sciences plc